TCMP
HALO icon

Thrive Capital Management (Pennsylvania)’s Halozyme HALO Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.34M Buy
+51,632
New +$3.64M 0.73% 67

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Thrive Capital Management (Pennsylvania)'s HALO Position: Q1 2026 in Review

Thrive Capital Management (Pennsylvania) opened a new position in Halozyme (HALO) in Q1 2026: 51,632 shares worth $3.34M. The stake represents 0.73% of the portfolio and ranks #67 among its holdings.

635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Thrive Capital Management (Pennsylvania) held 51,632 shares of Halozyme worth $3.34M as of Q1 2026.
  • Halozyme was a new Thrive Capital Management (Pennsylvania) position in Q1 2026.
  • Halozyme made up 0.73% of Thrive Capital Management (Pennsylvania)'s portfolio in Q1 2026, its #67 holding.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q1 2026, filed 27 Apr 2026.